Fresenius reported 8.22B in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akzo Nobel AKZA:NA 2.13B 167M
Alcon AG ALC:SW 1.88B 100M
AstraZeneca AZN:LN 7.09B 1.67B
BASF BAS:GR 17.44B 348M
Bayer BAYN:GR 13.14B 3.89B
Davita Healthcare Partners DVA:US $ 2426.03M 48.64M
DSM DSM:NA € 2004M 235M
E.ON EOAN:GR 12.36B 4.54B
Fresenius FRE:GR 8.22B 247M
Fresenius Medical Care FME:GR 3.9B 160M
Getinge GETIB:SS 5.38B 173M
Givaudan GIVN:VX 2.76B 123M
GlaxoSmithKline GSK:LN 6.42B 692M
GN Store Nord GN:DC 3.19B 204M
Hikma Pharmaceutical HIK:LN 873M 27M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.82B 233M
Novartis NOVN:VX 9.82B 464M
Philips PHIA:NA € 4145M 266M
RWE RWE:GR 3.14B 1.13B
William Demant Holding WDH:DC 7.37B 399M